Finn Sawyer Access to Cancer Testing Act

This bill expands Medicare, Medicaid, and CHIP coverage for specific cancer diagnostic tests, directly affecting cancer patients enrolled in these programs. It requires Medicare to cover genetic tests like DNA sequencing (80% of cost) and limits testing frequency to once at diagnosis, once for recurrence, and as needed for treatment planning. Medicaid and CHIP must include these tests as mandatory coverage starting January 1, 2027, with states given flexibility to comply via state legislation. The bill also mandates a new HHS education program to inform doctors and the public about genomic testing for cancer care.